Loading the company…
Loading the company…
No clearances or recalls under the mapped product codes.
All companies · Product and company coverage
In the last ten years FDA made 4 decisions for Kls Martin (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 0 procedure families, the most in 2026 (1). The latest was on 2026-02-20.
In 2025, Kls Martin reported engagement with 9 surgeons and other clinicians in the states MedaRep covers, worth $436K in consulting, speaking, meals and travel for its device products, the most in Maryland ($158K to 1). Royalties are left out.
| KLS Martin Cannulated Headless Screws |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Kls Martin.
Spend tied to a procedure counts the payments whose product names it. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing.Top states by spend: Maryland ($158K, 1 engaged), California ($157K, 3 engaged), New York ($99K, 2 engaged), South Dakota ($15K, 1 engaged), Connecticut ($5,924, 1 engaged).